News archive for Department of Global Public Health and Primary Care

A new study from IGS shows that survivors of cancer in young ages (<25 years) receive social security benefits four times more often than the cancer-free population.

Social Pharmacy research from Bergen is presented in the March edition of International Innovation, a publication which disseminate international research work to government bodies and potential sponsors, as well as other research institutions.

In a new publication based on master theses, the predictive validity of ÖMPQ was compared with the clinicians prognostic assessment of pain and functional outcome after 8 weeks of manual therapy treatment.

The PhD candidate Sara Ghaderi has recently published an article in Cancer Causes and Control about changes in risk of cancer death among young patients (0-24 years). The results show that the difference in risk of deaths between the cancer patients and the general population has been substantially reduced since 1965.

Håkon Hofstad presents a poster with first results from the ESD stroke Bergen study at World Federation for Neurorehabilitation congress in Melbourne

Due to her passion for teaching in Social Pharmacy and the involvement in the Masters Programme in Pharmacy in general, Associate Professor Kjersti Bakken has been honoured with the Generica Award 2011.

27.-29. april: Peter O’Sullivan & Kjartan Vibe Fersum: Classification based cognitive functional therapy (CB-CFT); 13.-16. juni: Linda-Joy Lee: Treating the whole person – the Integrated systems model for pain & disability; 18.-20. juni: Linda-Joy Lee: Restoring form and function of the abdominal wall after pregnancy

The core research groups at CIH have both received the grade “Excellent” by an international expert panel which has evaluated the medicine and health research in Norway.